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Abstract
Introduction: Inflammation of the synovial membrane plays an important role in the pathophysiology of
osteoarthritis (OA). The synovial tissue of patients with initial OA is characterized by infiltration of mononuclear cells
and production of proinflammatory cytokines and other mediators of joint injury. The objective was to evaluate the
effect of low-level laser therapy (LLLT) operating at 50 mW and 100 mW on joint inflammation in rats induced by
papain, through histopathological analysis, differential counts of inflammatory cells (macrophages and neutrophils),
as well as gene expression of interleukin 1-beta and 6 (IL-1b and IL-6), and protein expression of tumor necrosis
factor alpha (TNFa).
Methods: Male Wistar rats (n = 60) were randomly divided into four groups of 15 animals, namely: a negative
control group; an inflammation injury positive control group; a 50 mW LLLT group, subjected to injury and treated
with 50 mW LLLT; and a 100 mW LLLT group, subjected to injury and treated with 100 mW LLLT. The animals
were subject to joint inflammation (papain solution, 4%) and then treated with LLLT (808 nm, 4 J, 142.4 J/cm2, spot
size 0.028 for both groups). On the day of euthanasia, articular lavage was collected and immediately centrifuged;
the supernatant was saved for analysis of expression of TNFa protein by enzyme-linked immunosorbent assay and
expression of IL-1b and IL-6 mRNA by real-time polymerase chain reaction. A histologic examination of joint tissue
was also performed. For the statistical analysis, analysis of variance with Tukey’s post-hoc test was used for
comparisons between each group. All data are expressed as mean values and standard deviation, with P < 0.05.
Results: Laser treatment with 50 mW was more efficient than 100 mW in reducing cellular inflammation, and
decreased the expression of IL-1b and IL-6. However, the 100 mW treatment led to a higher reduction of TNFa
compared with the 50 mW treatment.
Conclusions: LLLT with 50 mW was more efficient in modulating inflammatory mediators (IL-1b, IL-6) and
inflammatory cells (macrophages and neutrophils), which correlated with the histology that showed a reduction in
the inflammatory process.
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Introduction
Osteoarthritis (OA) is a disease that involves damage to
the cartilage and the subchondral bone. The concept
that synovial inflammation contributes to the develop-
ment of OA is relatively recent (1990), and since then
has been gaining strength [1].
Histological changes seen in the synovial membrane in
OA generally include characteristics indicating an
inflammatory synovitis; more specifically, the changes
include a variety of abnormalities such as synovial lining
hyperplasia, infiltration of macrophages and lympho-
cytes, neoangiogenesis, and fibrosis [2]. Inflammation of
the synovial membrane plays a key role in the pathophy-
siology of OA. Immunohistochemical analysis confirmed
that the synovial tissue of patients with early OA is
characterized by infiltration of mononuclear cells and
production of proinflammatory cytokines and other
mediators of articular damage [3].
Several studies indicate that macrophages are involved
in OA pathophysiology, where they produce growth fac-
tors such as vascular endothelial growth factor and
inflammatory cytokines such as interleukin (IL)-1b and
tumor necrosis factor alpha (TNFa), and that cytokines
produced by macrophages may amplify inflammation in
joints [4-7]. This inflammation induces synovial cells to
produce additional cytokines and chemokines as well as
matrix metalloproteinases. Moreover, macrophages pre-
sent in the synovial fluid of OA express various recep-
tors that mediate the inflammatory cascade [8].
Synovial inflammation is an important source of both
proinflammatory and anti-inflammatory mediators, and
these have a role in OA. IL-1b and TNFa produced by
synovial cells induce a cascade of degradation, leading
to joint injury. These mediators, in particular, interleu-
kins (IL-1b and TNFa), chemokines, growth factors, and
matrix metalloproteinases are found in the synovial fluid
(synthesized by synoviocytes, chondrocytes, and infiltrat-
ing leukocytes) and they affect the cellular function of
articular tissues [9-13].
According to Pelletier and colleagues, the main goals
for the control of OA are to reduce symptoms, mini-
mize disability, and limit the progression of structural
changes [14]. The understanding of the role of catabolic
factors in cartilage degradation, as well as the effects of
synovial inflammation and cytokines on disease progres-
sion, has improved substantially in the past two decades.
This knowledge provides the framework necessary to
design strategies for the control of this articular disease.
Given the above, the search for effective therapies has
focused on treatment modalities that modulate the
expression of these mediators [15-17]. Low-level laser
treatment (LLLT) therapy has great potential utility in
this regard, since several studies have shown that it can
regulate interleukin and inflammatory mediator expres-
sion [18-23] and can also reduce inflammatory signs
and symptoms that are present in osteoarthritis [24-26].
The present study therefore aimed to evaluate the
effect of LLLT operated at 50 mW and 100 mW and
using identical laser parameters (except for power den-
sity and time of irradiation) on acute joint inflammation
induced by infiltration of 4% papain in the rat knee.
Materials and methods
Animals
The sample population consisted of 60 male Wistar rats
(Norvegicus albinus), 90 days old, weighing 250 to 300 g.
The animals were obtained from the animal housing
facility of the Universidade Nove de Julho (Brazil) and
were kept under controlled conditions of light and tem-
perature, with free access to water and chow. All experi-
mental procedures were approved by the Institutional
Research Ethics Committee (AN 0016/2011), and were
according to the guidelines of the Brazilian College for
Animal Experimentation as well as the standards of the
International Council for Laboratory Animal Science.
Experimental groups
Sixty animals were randomly distributed into four
groups of 15 animals each. The first group (control) did
not receive any kind of intervention; the second group
(injury), received induction but did not receive any
treatment; the third group (LLLT 50 mW) was treated
with LLLT at 50 mW; and rats of the fourth group
(LLLT 100 mW) were treated with LLLT at 100 mW.
All the groups were evaluated 24 hours post injury (five
animals per group, at each experimental time point).
Papain-induced inflammation
The animals were anesthetized with an intramuscular
injection of a 7% ketamine solution (Cetamin; Syntec,
Cotia, SP, Brazil) and 0.3% xylene solution (Xilazin; Syn-
tec) at a proportion of 2:1 (0.2 ml/100 g). The induction
of OA was then performed following previously pub-
lished methods [27,28]. Specifically, 200 μl injections
were administered in the right knee of the hind leg of
each animal with a 4% papain solution dissolved in 10
ml saline solution, to which 10 ml cysteine solution
(0.03 M) was added. This solution was used as the acti-
vator to produce cartilage injury. The animals were then
immediately submitted to the administration of LLLT.
Low-level laser therapy
An arsenide and aluminum gallium-type diode laser
with a wavelength of 808 nm from Photon Laser III
DMC (Sao Carlos, SP, Brazil) was used. The optical
power was calibrated using a Newport multifunction
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optical meter (Model 1835C; Newport Corporation,
Irvine, CA, USA). The dose and parameters are sum-
marized in Table 1.
Irradiation
Laser irradiation was given transcutaneously at two
points: medial and lateral. Laser irradiation was per-
formed immediately after the papain-cysteine injection,
on the right knee in groups at power output of 50 and
100 mW. The control and injury groups received no
treatment and served as the negative and positive control
groups, respectively, for the comparative histomorpho-
metric analysis. Animals were immobilized by means of
grip and were irradiated at an angle of 90° at the surface
of the tissue.
Sample collections
After receiving the treatment, on the day of euthanasia
a procedure for obtaining the washed articular synovial
fluid was performed. The articular cavity was washed
with 1 ml physiologic serum into the intracapsular
knee space, the material was immediately centrifuged
at 1,500 rpm/5 minutes, as described previously [29],
and the supernatant was stored at -80°C for analysis of
inflammatory mediators.
Total and differentiated cell counts
Articular synovium was washed by injecting 200 μl
phosphate-buffered saline (PBS) in the joint cavity,
because much material (washed) was recovered
(usually around 20 to 30 μl). The recovered lavage was
centrifuged at 1,500 rpm for 5 minutes, and the cell
pellet was suspended in 200 μl PBS. Total cells were
then counted in a hemocytometer (Neubauer chamber,
10 μl; diluting solution, Turk ’s solution 1:5). The
remaining articular material was washed thoroughly
and used for the differential cell count (neutrophils,
eosinophils, macrophages, and lymphocytes). For this
counting, the washed joint was processed in a
cytocentrifuge (Eppendorf, Hamburg, Germany) at
450 rpm for 6 minutes, and the slides containing the
cell pellet were stained with Diff-Quick. As shown in
previous studies, 300 cells were counted on each slide
[29,30].
Evaluation of inflammatory mediators (IL-1b, IL-6)
The amount of IL-1b and TNFa in washed articular
synovium was quantified using the enzyme-linked
immunosorbent assay, as per the manufacturer’s instruc-
tions (R&D Systems, Minneapolis, MN, USA.). For this
purpose, 96-well plates were coated with 100 ml mono-
clonal antibody for each cytokine: anti-IL-1b and TNFa
diluted in sodium carbonate buffer (0.1 M, pH 9.6). The
plates were incubated (4°C) for 18 hours. For blocking,
the plates were washed four times with PBS containing
0.05% Tween 20 and then filled with 300 μl/well of
blocking solution (3% gelatin in PBS containing 0.05%
Tween 20 (Sigma, St. Louis, MO, USA) at 37°C for 3
hours before being subjected to a new cycle of washes.
Next, 100 ml properly diluted samples or standards of
recombinant cytokines were added to the plate and
incubated for 18 hours at 4°C. After washing, 100 μl
respective biotinylated antibodies specific for the detec-
tion of each cytokine was added and left for 1 hour at
room temperature. After washing the plates, the volume
of 100 μl streptavidin-peroxidase was added and left for
1 hour at room temperature (22°C) followed by further
washes. The reaction was visualized by adding 100 μl/
well solution of 3,3’,5,5’-tetramethylbenzidine and
stopped by adding 50 μl/well sulfuric acid (2 N). The
reading was performed in a Spectrum Max Plus 384
spectrophotometer (Molecular Devices Corporation,
Sunnyvale, CA, USA) at a wavelength of 450 nm with
correction at 570 nm. The sample concentrations were
calculated from standard curves obtained with recombi-
nant cytokines. The limit of detection for IL-1b and
TNFa was 1.95 pg/ml, while that for IL-6 was 3.13 to
300 pg/ml [19].
Quantitative reverse transcriptase-polymerase chain
reaction
One microgram of total RNA was used for cDNA synth-
esis and real-time polymerase chain reaction (PCR) gene
expression analysis. Initially, contaminating DNA was
removed using DNase I (Invitrogen Life Technologies,
Carlsbad, CA, USA) at a concentration of 1 unit/μg RNA
in the presence of 20 mM Tris-HCl, pH 8.4, containing 2
mM MgCl2 for 15 minutes at 37°C, followed by incuba-
tion at 95°C for 5 minutes for enzyme inactivation.





















808 GaAlAs 50 0.028 1.78 4 142.4 80
100 mW
LLLT
808 GaAlAs 100 0.028 3.57 4 142.4 40
GaAlAs - arsenide and aluminum gallium; l, - wavelength; LLLT - low-level laser therapy.
Alves et al. Arthritis Research & Therapy 2013, 15:R116
http://arthritis-research.com/content/15/5/R116
Page 3 of 11
Reverse transcription was then carried out in a 200 μl
reaction mixture in the presence of 50 mM Tris-HCl, pH
8.3, 3 mM MgCl2, 10 mM dithiothreitol, 0.5 mM dNTPs,
and 50 ng random primers with 200 units of Moloney
murine leukemia virus-reverse transcriptase (Invitrogen).
The reaction conditions were as follows: 20°C for 10 min-
utes, 42°C for 45 minutes, and 95°C for 5 minutes.
The reaction product was amplified by real-time PCR
on the 7000 Sequence Detection kit using the SYBR-
Green core reaction system (ABI Prism, Applied Biosys-
tems, Foster City, California, USA). The thermal cycling
conditions were as follows: 50°C for 2 minutes, then 95°
C for 10 minutes, followed by 40 cycles at 95°C for 15
seconds and 60°C for 1 minute. Experiments were per-
formed in triplicate for each data point.
IL-10 and IL-1b mRNA abundance was quantified as a
relative value compared with an internal reference, b-
actin, whose abundance did not change between the
varying experimental conditions. Primers used for real-
time PCR are as follows: IL-6 [GenBank:E02522], for-
ward primer 5’-TCCTACCCCAACTTCCAATGCTC-3’
and reverse primer 5’-TTGGATGGTCTTGGTCCT-
TAGCC-3’; and IL-1 [GenBank:M98820], forward pri-
mer 5’-CACCTCTCAAGCAGAGCACAG-3’ and reverse
primer 5’-GGGTTCCATGGTGAAGTCAAC-3’ [20].
Euthanasia
At the end of each treatment, animals of each group
were identified, weighed, and subsequently euthanized
by inhalation of carbon dioxide. This method confers
rapid loss of consciousness in response to hypoxia
attributed to depression of vital centers and is per-
formed in a carbon dioxide chamber. The tibio-femoral
articulation of the right hind leg of each animal was
separated for analysis of the cartilaginous tissue of the
knee. The material was immediately fixed using a 10%
buffered formaldehyde solution and submitted to histo-
logical procedures.
Histological procedures and histopathological analysis
The material was decalcified with ethylenediamine tetraa-
cetic acid and submitted to the classic histological method
for embedment in paraffin, dehydration in increasing con-
centrations of alcohol, clearing with xylol in order to allow
the penetration of paraffin, impregnation in paraffin baths
and insertion in molds, cross-sectional cuts to a thickness
of 5 μm, and finally mounting on a synthetic balsam. Sec-
tions were then stained with hematoxylin and eosin to
perform histopathological analysis.
Statistical analysis
The data were tabulated using Microsoft Excel 2007
software and initially assessed for normality using the
Shapiro-Wilk test. As normal distribution was observed,
analysis of variance with Tukey’s post-hoc test was used
for comparisons between 7, 14, and 21 days within each
group as well as between the control, injury, 50 mW
LLLT, and 100 mW LLLT groups. All data are expressed
as mean and standard deviation values. The GraphPad
Prism 5 software program (GraphPad Software, San
Diego, CA, USA) was used, with significant difference
from the null hypothesis considered when P < 0.05.
Results
Differential inflammatory cell counting
The data presented show the total count of viable cells
in washed joint fluid that were enumerated in the
Neubauer chamber. The control group had fewer cells
(6.8 ± 0.5) than the injury group (72.8 ± 5.3) whereas
the 50 mW LLLT group (32.3 ± 0.8) and the 100 mW
LLLT group (45.8 ± 2.3) had intermediate values. In
the differential analysis for neutrophils, the groups
treated with 50 mW LLLT (18.88 ± 5.3) and 100 mW
LLLT (19.88 ± 3.2) showed a reduction in the absolute
number of neutrophils compared with the injury group
(48.7 ± 7.3); however, only the 50 mW group showed
no statistical difference (P > 0.05) when compared with
the control group (4.1 ± 0.9). This clearly demonstrates
that LLLT reduced the number of neutrophils to
approximately the level observed in the control group
(Figure 1A).
In Figure 1B the effect of LLLT on the differential
count of macrophages can be seen. By statistical analy-
sis (analysis of variance) we found statistical difference
for the injury group and 100 mW LLLT group com-
pared to control group (P < 0.05)., The 50 mW LLLT
group has significant difference compared to injury
group and 100 mW LLLT group (P < 0.05). No differ-
ence was observed between 50 mW LLLT group and
control group (P > 0.05).
Effect of LLLT on IL-1b mRNA expression in articular
synovial lavage
In Figure 2A, we can observe that there is a significant
difference between the control group and the group
challenged with joint injury (P < 0.05) in expression of
IL-1b. Treatment with 50 mW LLLT reduced the
expression of IL-1b to values similar to the control
group, and significantly lower than the injury group
(P < 0.05). In the 100 mW LLLT group, despite
not having shown a statistically significant difference
(P > 0.05) compared with the control group, there was
a reduction in IL-1b expression in this treatment
group.
Effect of LLLT on IL-6 mRNA in articular synovial lavage
Figure 2B represents the effect of LLLT on IL-6 mRNA
expression. In these experiments, IL-6 expression was
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significantly increased after papain injection when com-
pared with animals from the control groups. Only treat-
ment with 50 mW LLLT was markedly efficient in
reducing papain-induced IL-6 mRNA expression.
Effect of LLLT on the protein expression of TNFa in
articular synovial lavage
Figure 3 shows the results of analysis of protein expres-
sion of TNFa in the articular synovial lavage. We can
observe that the injury inflammation induced by papain
led to a statistically significant increased expression of
TNFa compared with the control group and the 50
mW LLLT group (P < 0.05). However, the 100 mW
LLLT group showed a significantly lower expression of
TNFa compared with the injury group (P < 0.001), simi-
lar to values in the control group.
Histological analysis
Upon histological examination, the control group had
general features that were consistent with synovial joint
Figure 1 Analysis of the articular lavage 24 hours after induced papain injury. (A) Absolute neutrophil count calculated from a differential
count determined in cytospin preparations stained with the Diff-Quik stain. *P < 0.05 and **P < 0.001, Tukey’s test compared with the control
group. ##P < 0.001, Tukey’s test compared with the injury group. (B) Absolute macrophage count calculated from a differential count
determined in cytospin preparations stained with Diff-Quik stain. **P < 0.001, Tukey’s test compared with the control group. ##P < 0.001, Tukey’s
test compared with the injury group. ξP < 0.05 Tukey’s test compared with the 50 mW low-level laser therapy group. Results expressed as mean
± standard error of the mean. LAS: Washed Articular Synovium.
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normality. The joint spaces did not have inflammatory
exudate, and the synovial membranes had thickened
intima and subintima showing typical characteristics.
The surfaces of coated articular hyaline cartilage were
homogeneous, and there was active endochondral ossifi-
cation of the epiphysis. The control group also had epi-
physeal bone marrow with a normal pattern that was
filled with red bone marrow. The articular meniscus
consisted of thick collagen fibers and chondrocytes, and
ossification was present (Figure 4A, B).
In the injury group (induction of the inflammatory
process without any treatment) the synovial joint
showed acute inflammatory process. The joint spaces
had fibrinous and hyaline material that adhered to the
Figure 2 Effect of low-level laser therapy on IL-1b and IL-6 RNA expression in articular lavage fluid. (A) IL-1b expression measured by
real-time polymerase chain reaction (PCR) in articular wash fluid. *P < 0.05, Tukey’s test compared with the control group. #P < 0.05, Tukey’s test
compared with the injury group. (B) IL-6 RNA expression measured by real-time PCR of articular lavage fluid. *P < 0.05, Tukey’s test compared
with the control group. #P < 0.05, Tukey’s test compared with the injury group. Results expressed as mean ± standard error of the mean. LLLT,
low-level laser therapy.
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surface of the synovial membrane, and some areas had
an acute inflammatory infiltrate. The synovial mem-
brane had an intima with normal thickness, but the
subintimal layer showed signs of acute inflammatory
infiltrate and dilated blood vessels. Similar to that in
the control group, the surfaces coated with articular
hyaline cartilage were homogeneous and the epiphyseal
bone marrow had the normal fill of red bone marrow.
Moreover, the epiphysis of the bone marrow presents
antagonistic in the process of cellular degeneration
(Figure 4C, D).
The group treated with 50 mW LLLT showed synovial
joints with few morphological changes, such as high
amounts of fibroblast cells and presence of discrete
inflammatory cells (a few neutrophils) in the underlying
connective tissue of the anterior cruciate ligament (that
is, the joint capsule; Figure 4E, F).
The group treated with 100 mW LLLT showed signs of
an acute inflammatory process in the synovial joint. The
articular spaces were filled with acute inflammatory infil-
trate (exudate) and the presence of red blood cells and
hyaline material. Apart from this, the synovial membrane
had an intima of normal thickness. The layer subintima
showed signs of acute inflammatory infiltration and dilated
blood vessels. Surfaces coated with articular hyaline carti-
lage were homogeneous, and the epiphyseal bone marrow
had a normal pattern and was filled with red bone mar-
row. The articular meniscus consisted of thick collagen
fibers and chondrocytes, as shown in Figure 4G, H.
Discussion
OA is not a simple wear-and-tear phenomenon, but an
active process that is a part of the reparative response to
injury. The disease affects not only the cartilage but also
the entire joint structure, including the subchondral
bone, synovium, and joint capsule. The exact cause of
OA is not yet known. Studies have indicated that
inflammation of the synovium may play an important
role in the pathogenesis of OA. Proinflammatory cyto-
kines, particularly IL-1b and TNFa, are synthesized by
synoviocytes, chondrocytes, and infiltrating leukocytes
during the disease process [12].
Several studies have demonstrated the effectiveness of
LLLT in treating the inflammatory process, and these
studies indicate the modulating property of laser light
towards anti-inflammatory and proinflammatory media-
tors [19-21,23]. However, other studies have shown a
failure of LLLT in conditions involving joint damage
[31,32].
In this study, we used the protocol of Murat and col-
leagues for OA [28]. However, we performed an evalua-
tion of the inflammatory changes after 24 hours of
induction with papain at 4%, and compared the results
of LLLT operating at powers of 50 mW and 100 mW.
We used histological analysis and differential counts of
inflammatory cells, with an emphasis on neutrophils and
macrophages, given that macrophages are the key source
of inflammatory cytokines [5-8] that act at the beginning
of damage to articular cartilage.
Figure 3 TNFa concentration in articular lavage fluid 24 hours after induction of papain injuries. Comparison of mean and standard
deviation of the concentration of tumor necrosis factor alpha (TNFa) obtained by enzyme-linked immunosorbent assay in articular lavage fluid
24 hours after induction of papain injuries. *P < 0.05 and **P < 0.001, Tukey’s test compared with the control group. ##P < 0.001, Tukey’s test
compared with the injury group. ξP < 0.05, Tukey’s test compared with the 50 mW low-level laser therapy (LLLT) group.
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Figure 4 Photomicrographs of histological preparations 24 hours after induction of the inflammation process with 4% papain. (A)
Slight presence of hyaline material in the joint space due to plasma extravasation (arrow). (B) Joint surfaces under conditions of normal
meniscus and articular signs of ossification (arrow). (C) Intense acute inflammatory exudate filling the part of the joint space (arrow). (D)
Neutrophil accumulation in the connective tissue underlying the synovial membrane (arrow). (E), (F) Specimens of normal tissue: (E) intimal layer
of the synovial membrane presents usual thickness (arrow), whereas few inflammatory cells are observed in the isolated underlying layer (star);
(F) meniscus and articular joint surfaces show signs of tissue integrity. (G) Presence of both the acute inflammatory exudate synovial membrane
(star) as well as in the joint space and an association with fibrin hyaline material (arrow). (H) Cellular degenerative process in the marrow spaces
of the epiphyses of the joint (arrow). Stained with hematoxylin and eosin 40×. Scale bar, 20 μm. CH: Hyaline Cartilage; EA: Articular Space; MA:
Articular Meniscus.
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According to Kennedy and colleagues, synovial macro-
phages are one of the resident cell types in the synovial
tissue and while they remain relatively quiescent in the
healthy joint, they become activated in the inflamed joint
and, along with infiltrating monocytes/macrophages, reg-
ulate the secretion of proinflammatory cytokines and
enzymes involved in driving the inflammatory response
and joint destruction [6]. Synovial macrophages are posi-
tioned throughout the sub-lining layer and lining layer at
the cartilage-pannus junction and they mediate articular
destruction.
We also performed an analysis of gene expression of
the cytokines IL-1b and IL-6 and TNFa protein expres-
sion, since several studies have shown that inhibition of
these cytokines may interfere with the degeneration of
articular cartilage and subchondral bone in OA and
rheumatoid arthritis [14-16].
Our results show a reduction in both IL-1b and IL-6
expression at the two LLLT operating potencies. How-
ever, 50 mW LLLT led to a statistically significant reduc-
tion in expression of IL-1b and IL-6 to values obtained in
the control group. This observation is consistent with
several studies that show modulation of these cytokines
by LLLT [18,23,33]. Pallotta and colleagues conducted a
study to examine the response to 100 mW LLLT at dif-
ferent times and doses in a model of joint inflammation
induced by kaolin plus carrageenan. The authors analyzed
several inflammatory mediators, including IL-1b and IL-6,
and concluded that LLLT acts by modulating the inflam-
matory process, and possibly stimulates the production of
anti-inflammatory mediators [23].
We also observed in our study that the two groups
treated with LLLT (50 mW and 100 mW) had a lower
neutrophil count compared with the injury group, similar
to those obtained in the control group, indicating that
LLLT was able to reduce the migration of neutrophils in
the initial inflammatory phase. This was also observed in
the histological analysis, although these results indicate a
higher efficiency of 50 mW LLLT treatment in attenua-
tion of the general inflammatory process.
These results point to an increase in the modulation of
cytokines and inflammatory cells (neutrophils and macro-
phages), when irradiated by LLLT operating at 50 mW.
However, we cannot discard the results of the 100 mW
group, primarily with regard to the expression of TNFa.
A study by Pezelj-Ribaric and colleagues in subjects with
burning mouth syndrome before and after treatment with
LLLT (685 nm continuous wave, 30 mW output power,
3.0 J/cm2) that analyzed the expression of TNFa and IL-6
in saliva showed a statistically significant reduction in sali-
vary levels of both after treatment with LLLT [33].
Guo and colleagues performed a study that evaluated
and compared the effects of millimeter waves, pulsed
electromagnetic fields, ultrasound, LLLT, and short-wave
diathermy on the serum levels of TNFa, chondrocyte
apoptosis, caspase-3 and caspase-8, in an experimental
model of OA in rabbit knees, and they suggested that
their findings may shed light on the efficacy of various
physical treatments in OA management [34]. The same
authors suggested that LLLT was not the ideal treatment
modality for OA. This contrasts with our findings that
TNFa protein was reduced in both groups treated with
LLLT, although only in the 100 mW group was this sta-
tistically significant. However, establishing an accurate
comparison with the study performed by Guo and collea-
gues is difficult since the authors reported LLLT as fol-
lows: ‘LLLT for 10 min: wavelength of 810 nm, the
output power of the laser ranged from 0 mW to 1000
mW and could be adjusted by a controller. The radius of
laser spot was approximately 5 mm with a distance of 1
cm between the surface of the knee and the lens in all
the treatments’ [34]. With this description is impossible
to know the mean power output and consequently also
the power density, energy density and energy delivered.
We note that the energy density (4 J·cm2) was the
same for both groups (50 mW and 100 mW), but the
irradiation time was twofold longer in the 50 mW
group. We infer that this latter difference weighed
importantly in the results. This assertion is supported
by the results of the study by Castano and colleagues,
who demonstrated that a longer lighting period is more
effective than short times, regardless of the total influ-
ence or irradiance [35].
Our results provide evidence of LLLT-dependent
reduction of IL-1b, IL-6 and TNFa, and the therapy’s
ability to inhibit proliferation of inflammatory cells
makes it a suitable treatment for synovitis associated
with the early stages of OA. The results also indicate
that a better understanding of the role of LLLT in mod-
ulating these mediators can provide the basis for future
therapeutic interventions.
Conclusion
Despite both power outputs tested in this study showing
positive results, LLLT with 50 mW was more efficient
in modulating inflammatory mediators (IL-1b, IL-6) and
inflammatory cells (macrophages and neutrophils), and
led to histological signs of an attenuated inflammatory
process.
Abbreviations
OA: osteoarthritis; LLLT: low-level laser therapy; IL: interleukin; TNF: tumor
necrosis factor; PBS: phosphate-buffered saline; PCR: polymerase chain
reaction.
Competing interests
ECPLJ receives research support from Multi Radiance Medical (Solon, OH -
USA), a laser device manufacturer. Multi Radiance Medical had no role in the
planning of this experiment, and the laser device used was not theirs. They
Alves et al. Arthritis Research & Therapy 2013, 15:R116
http://arthritis-research.com/content/15/5/R116
Page 9 of 11
had no influence on study design, data collection and analysis, decision to
publish, or preparation of the manuscript. The remaining authors declare
that they have no competing interests.
Authors’ contributions
ACAA, PdTCdC and RdPV contributed to the conception and design,
acquisition of data, analysis and interpretation of data and drafting the
manuscript. SAdS, ECPLJ, APL and RA were involved in data interpretation,
statistical analysis and manuscript preparation. PdTCdC and JASJ conceived
the study, participated in its design and coordination, and helped to draft
the manuscript. All authors contributed to revising the manuscript critically
for important intellectual content, and read and approved the manuscript
for publication.
Acknowledgements
The authors wish to thank FAPESP for the master scholarship granted to
ACAA (FAPESP process n° 2011/04834-8). Support for this study was from
the Brazilian Research Council - CNPq (Research Productivity scholarship -
process n° 307665/2012-7).
Authors’ details
1Postgraduate Program in Rehabilitation Sciences, Universidade Nove de
Julho (UNINOVE), Rua Vergueiro 235, 01504-001 São Paulo, SP, Brazil.
2Postgraduate Program in Biophotonics Applied to Health Sciences,
Universidade Nove de Julho (UNINOVE), Rua Vergueiro 235, 01504-001 São
Paulo, SP, Brazil. 3Department of Physical Therapy, Universidade Nove de
Julho (UNINOVE), Rua Vergueiro 235, 01504-001 São Paulo, SP, Brazil.
Received: 1 March 2013 Revised: 6 June 2013
Accepted: 12 September 2013 Published: 12 September 2013
References
1. Bondeson J, Blom AB, Wainwright S, Hughes C, Caterson B, van den
Berg WB: The role of synovial macrophages and macrophage-produced
mediators in driving inflammatory and destructive responses in
osteoarthritis. Arthritis Rheum 2010, 62:647-657.
2. Scanzello CR, Goldring SR: The role of synovitis in osteoarthritis
pathogenesis. Bone 2012, 51:249-257.
3. Benito MJ, Veale DJ, FitzGerald O, van den Berg WB, Bresnihan B: Synovial
tissue inflammation in early and late osteoarthritis. Ann Rheum Dis 2005,
64:1263-1267.
4. Bondeson J, Wainwright SD, Lauder S, Amos N, Hughes CE: The role of
synovial macrophages and macrophage-produced cytokines in driving
aggrecanases, matrix metalloproteinases, and other destructive and
inflammatory responses in osteoarthritis. Arthritis Res Ther 2006, 8:R187.
5. Bondeson J, Wainwright SD, Lauder S, Amos N, Hughes CE: The role of
synovial macrophages and macrophage-produced cytokines in driving
aggrecanases, matrix metalloproteinases, and other destructive and
inflammatory responses in osteoarthritis. Arthritis Res Ther 2006, 8:R187.
6. Kennedy A, Fearon U, Veale DJ, Godson C: Macrophages in synovial
inflammation. Front Immunol 2011, 2:52.
7. Young L, Katrib A, Cuello C, Vollmer-Conna U, Bertouch JV, Roberts-
Thomson PJ, Ahern MJ, Smith MD, Youssef PP: Effects of intraarticular
glucocorticoids on macrophage infiltration and mediators of joint
damage in osteoarthritis synovial membranes: findings in a double-
blind, placebo-controlled study. Arthritis Rheum 2001, 44:343-350.
8. Young L, Katrib A, Cuello C, Vollmer-Conna U, Bertouch JV, Roberts-
Thomson PJ, Ahern MJ, Smith MD, Youssef PP: Effects of intraarticular
glucocorticoids on macrophage infiltration and mediators of joint
damage in osteoarthritis synovial membranes: findings in a double-
blind, placebo-controlled study. Arthritis Rheum 2001, 44:343-350.
9. Yamairi F, Utsumi H, Ono Y, Komorita N, Tanaka M, Fukunari A: Expression
of vascular endothelial growth factor (VEGF) associated with
histopathological changes in rodent models of osteoarthritis. J Toxicol
Pathol 2011, 24:137-142.
10. Rübenhagen R, Schüttrumpf JP, Stürmer KM, Frosch KH: Interleukin-7 levels
in synovial fluid increase with age and MMP-1 levels decrease with
progression of osteoarthritis. Acta Orthop 2012, 83:59-64.
11. Goldring MB: The role of cytokines as inflammatory mediators in
osteoarthritis: lessons from animal models. Connect Tissue Res 1999, 40:1-11.
12. Ling PX, Zhang LN, Jin Y, He YL, Zhang TM: Effects of a hyaluronic acid
and low molecular weight heparin injection on osteoarthritis in rabbits.
Drug Discov Ther 2009, 3:146-150.
13. Fernandes JC, Martel-Pelletier J, Pelletier JP: The role of cytokines in
osteoarthritis pathophysiology. Biorheology 2002, 39:237-246.
14. Pelletier JP, Martel-Pelletier J, Abramson SB: Osteoarthritis, an
inflammatory disease: potential implication for the selection of new
therapeutic targets. Arthritis Rheum 2001, 44:1237-1247.
15. Santangelo KS, Nuovo GJ, Bertone AL: In vivo reduction or blockade of
interleukin-1β in primary osteoarthritis influences expression of
mediators implicated in pathogenesis. Osteoarthritis Cartilage 2012,
20:1610-1618.
16. Santangelo KS, Bertone AL: Effective reduction of the interleukin-1β
transcript in osteoarthritis-prone guinea pig chondrocytes via short
hairpin RNA mediated RNA interference influences gene expression of
mediators implicated in disease pathogenesis. Osteoarthritis Cartilage
2011, 19:1449-1457.
17. Biniecka M, Kennedy A, Ng VT, Chang TC, Balogh E, Fox E, Veale DJ,
Fearon U, O’Sullivan JN: Successful tumour necrosis factor (TNF) blocking
therapy suppresses oxidative stress and hypoxia-induced mitochondrial
mutagenesis in inflammatory arthritis. Arthritis Res Ther 2011, 13:R121.
18. Yamaura M, Yao M, Yaroslavsky I, Cohen R, Smotrich M, Kochevar IE: Low
level light effects on inflammatory cytokine production by rheumatoid
arthritis synoviocytes. Lasers Surg Med 2009, 41:282-290.
19. Laraia EM, Silva IS, Pereira DM, Dos Reis FA, Albertini R, de Almeida P, Leal
Junior EC, de Tarso Camillo de Carvalho P: Effect of low-level laser therapy
(660 nm) on acute inflammation induced by tenotomy of Achilles
tendon in rats. Photochem Photobiol 2012, 88:1546-1550.
20. de Lima FM, Villaverde AB, Albertini R, Corrêa JC, Carvalho RL, Munin E,
Araújo T, Silva JA, Aimbire F: Dual Effect of low-level laser therapy (LLLT)
on the acute lung inflammation induced by intestinal ischemia and
reperfusion: action on anti- and pro-inflammatory cytokines. Lasers Surg
Med 2011, 43:410-420.
21. de Lima FM, Bjordal JM, Albertini R, Santos FV, Aimbire F: Low-level laser
therapy (LLLT) attenuates RhoA mRNA expression in the rat bronchi
smooth muscle exposed to tumor necrosis factor-alpha. Lasers Med Sci
2010, 25:661-668.
22. Gao X, Xing D: Molecular mechanisms of cell proliferation induced by
low power laser irradiation. J Biomed Sci 2009, 16:4.
23. Pallotta RC, Bjordal JM, Frigo L, Leal Junior EC, Teixeira S, Marcos RL,
Ramos L, Messias Fde M, Lopes-Martins RA: Infrared (810-nm) low-level
laser therapy on rat experimental knee inflammation. Lasers Med Sci
2012, 27:71-78.
24. Lin YS, Huang MH, Chai CY: Effects of helium-neon laser on the
mucopolysaccharide induction in experimental osteoarthritic cartilage.
Osteoarthritis Cartilage 2006, 14:377-383.
25. Cho HJ, Lim SC, Kim SG, Kim YS, Kang SS, Choi SH, Cho YS, Bae CS: Effect
of low-level laser therapy on osteoarthropathy in rabbit. In Vivo 2004,
18:585-591.
26. Holden PK, Li C, Da Costa V, Sun CH, Bryant SV, Gardiner DM, Wong BJ: The
effects of laser irradiation of cartilage on chondrocyte gene expression
and the collagen matrix. Lasers Surg Med 2009, 41:487-491.
27. da Rosa AS, dos Santos AF, da Silva MM, Facco GG, Perreira DM, Alves AC,
Leal Junior EC, de Carvalho P de T: Effects of low-level laser therapy at
wavelengths of 660 and 808 nm in experimental model of osteoarthritis.
Photochem Photobiol 2012, 88:161-166.
28. Murat N, Karadam B, Ozkal S, Karatosun V, Gidener S: Quantification of
papain-induced rat osteoarthritis in relation to time with the Mankin
score. Acta Orthop Traumatol Turc 2007, 41:233-237.
29. Vieira RP, Claudino RC, Duarte AC, Santos AB, Perini A, Faria Neto HC,
Mauad T, Martins MA, Dolhnikoff M, Carvalho CR: Aerobic exercise
decreases chronic allergic lung inflammation and airway remodeling in
mice. Am J Respir Crit Care Med 2007, 176:871-877.
30. Vieira RP, Duarte AC, Claudino RC, Perini A, Santos AB, Moriya HT, Arantes-
Costa FM, Martins MA, Carvalho CR, Dolhnikoff M: Creatine
supplementation exacerbates allergic lung inflammation and airway
remodeling in mice. Am J Respir Cell Mol Biol 2007, 37:660-667.
31. Javadieh F, Bayat M, Torkaman G: Evaluation of low-level laser therapy
with a He-Ne laser on the healing of an osteochondral defect using a
biomechanical test. Photomed Laser Surg 2010, 28:423-428.
Alves et al. Arthritis Research & Therapy 2013, 15:R116
http://arthritis-research.com/content/15/5/R116
Page 10 of 11
32. Bayat M, Javadieh F, Dadpay M: Effect of He-Ne laser radiation on healing
of osteochondral defect in rabbit: a histological study. J Rehabil Res Dev
2009, 46:1135-1142.
33. Pezelj-Ribarić S, Kqiku L, Brumini G, Urek MM, Antonić R, Kuiš D, Glažar I,
Städtler P: Proinflammatory cytokine levels in saliva in patients with
burning mouth syndrome before and after treatment with low-level
laser therapy. Lasers Med Sci 2013, 28:297-301, {AU Query: Confirm details}.
34. Guo H, Luo Q, Zhang J, Lin H, Xia L, He C: Comparing different physical
factors on serum TNF-α levels, chondrocyte apoptosis, caspase-3 and
caspase-8 expression in osteoarthritis of the knee in rabbits. Joint Bone
Spine 2011, 78:604-610.
35. Castano AP, Dai T, Yaroslavsky I, Cohen R, Apruzzese WA, Smotrich MH,
Hamblin MR: Low-level laser therapy for zymosan-induced arthritis in
rats: importance of illumination time. Lasers Surg Med 2007, 39:543-550.
doi:10.1186/ar4296
Cite this article as: Alves et al.: Effect of low-level laser therapy on the
expression of inflammatory mediators and on neutrophils and
macrophages in acute joint inflammation. Arthritis Research & Therapy
2013 15:R116.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Alves et al. Arthritis Research & Therapy 2013, 15:R116
http://arthritis-research.com/content/15/5/R116
Page 11 of 11
